Table 1 Clinical manifestations of systemic sclerosis patients
From: Serum defensin levels in patients with systemic sclerosis
Clinical manifestations | N (%) |
|---|---|
Lung Involvement | 20 (47.6) |
Pulmonary hypertension | 11 (31.4) |
Esophageal involvement | 13 (31) |
Intestinal involvement | 2 (4.8) |
Renal involvement | 2 (4.8) |
Telangiectasia | 20 (48.8) |
Raynaud’s phenomenon | 41 (97.6) |
Digital ulcer | 16 (36.8) |
Autoantibodies | |
ANA | 42 (100) |
Anti-Scl-70 | 27 (67.5) |
Anti- centromere | 10 (25) |
RNP | 0 |
SS-A | 9 (25.7) |
SS-B | 2 (5.7) |